newsfilter
← Latest News
GlobeNewswire·

Century Therapeutics to Participate in Upcoming Investor Conferences in March

PHILADELPHIA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ((‘Century', NASDAQ:IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune